Dietary weight loss and exercise effects on insulin resistance in postmenopausal women - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1016/j.amepre.2011.06.042.
Karen E Foster-Schubert, Ikuyo Imayama, Angela Kong, Liren Xiao, Carolyn Bain, Kristin L Campbell, Ching-Yun Wang, Catherine R Duggan, Cornelia M Ulrich, Catherine M Alfano, George L Blackburn, Anne McTiernan
Affiliations
- PMID: 21961463
- PMCID: PMC3185302
- DOI: 10.1016/j.amepre.2011.06.042
Randomized Controlled Trial
Dietary weight loss and exercise effects on insulin resistance in postmenopausal women
Caitlin Mason et al. Am J Prev Med. 2011 Oct.
Abstract
Background: Comprehensive lifestyle interventions are effective in preventing diabetes and restoring glucose regulation; however, the key stimulus for change has not been identified and effects in older individuals are not established. The aim of the study was to investigate the independent and combined effects of dietary weight loss and exercise on insulin sensitivity and restoration of normal fasting glucose in middle-aged and older women.
Design: Four-arm RCT, conducted between 2005 and 2009 and data analyzed in 2010.
Setting/participants: 439 inactive, overweight/obese postmenopausal women.
Interventions: Women were assigned to: dietary weight loss (n=118); exercise (n=117); exercise+diet (n=117); or control (n=87). The diet intervention was a group-based reduced-calorie program with a 10% weight-loss goal. The exercise intervention was 45 min/day, 5 days/week of moderate-to-vigorous intensity aerobic activity.
Main outcome measures: 12-month change in serum insulin, C-peptide, fasting glucose, and whole body insulin resistance (HOMA-IR).
Results: A significant improvement in HOMA-IR was detected in the diet (-24%, p<0.001) and exercise+ diet (-26%, p<0.001) groups but not in the exercise (-9%, p=0.22) group compared with controls (-2%); these effects were similar in middle-aged (50-60 years) and older women (aged 60-75 years). Among those with impaired fasting glucose (5.6-6.9 mmol/L) at baseline (n=143; 33%), the odds (95% CI) of regressing to normal fasting glucose after adjusting for weight loss and baseline levels were 2.5 (0.8, 8.4); 2.76 (0.8, 10.0); and 3.1 (1.0, 9.9) in the diet, exercise+diet, and exercise group, respectively, compared with controls.
Conclusions: Dietary weight loss, with or without exercise, significantly improved insulin resistance. Older women derived as much benefit as did the younger postmenopausal women.
Trial registration: This study is registered at Clinicaltrials.govNCT00470119.
Copyright © 2011 American Journal of Preventive Medicine. All rights reserved.
Figures
Figure 1
Flow of participants through the Nutrition and Exercise in Women (NEW) trial Note: DXA, dual emission X-ray absorptiometry
Comment in
- Exercise, diet, weight loss and glucose metabolism.
Zivkovic TB. Zivkovic TB. Climacteric. 2012 Oct;15(5):509-10. Climacteric. 2012. PMID: 23145449 No abstract available.
References
- International Diabetes Federation. Diabetes Atlas. 3. Brussels: International Diabetes Federation; 2006.
- Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995;75(3):473–86. - PubMed
- Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12. 4 years. Diabetes Care. 1999;22(2):233–40. - PubMed
- Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, Schmidt MI, et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care. 1999;22(7):1077–83. - PubMed
- Levitzky YS, Pencina MJ, D’Agostino RB, Meigs JB, Murabito JM, Vasan RS, et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol. 2008;51(3):264–70. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R25 CA057699/CA/NCI NIH HHS/United States
- R25 CA94880/CA/NCI NIH HHS/United States
- R25 CA094880/CA/NCI NIH HHS/United States
- 2R25CA057699-16/CA/NCI NIH HHS/United States
- U54-CA116847/CA/NCI NIH HHS/United States
- KL2 RR025015/RR/NCRR NIH HHS/United States
- R01 CA102504/CA/NCI NIH HHS/United States
- U54 CA116847/CA/NCI NIH HHS/United States
- R01 CA105204/CA/NCI NIH HHS/United States
- 5KL2RR025015-03/RR/NCRR NIH HHS/United States
- CAPMC/ CIHR/Canada
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical